Seminars in Liver Disease
Volume 38, Issue 3, 2018, Pages 181-192
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations (Review) (Open Access)
Lazarus J.V.* ,
Safreed-Harmon K. ,
Thursz M.R. ,
Dillon J.F. ,
El-Sayed M.H. ,
Elsharkawy A.M. ,
Hatzakis A. ,
Jadoul M. ,
Prestileo T. ,
Razavi H. ,
Rockstroh J.K. ,
Wiktor S.Z. ,
Colombo M.
-
a
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Calle Roselló 132, Barcelona, ES-08036, Spain
-
b
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Calle Roselló 132, Barcelona, ES-08036, Spain
-
c
Department of Surgery and Cancer, Imperial College, London, United Kingdom
-
d
Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom
-
e
Department of Pediatrics, Ain Shams University, Cairo, Egypt
-
f
University Hospitals Birmingham, Mindelsohn Way, Birmingham, United Kingdom
-
g
Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece
-
h
Department of Nephrology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
-
i
Infection Diseases Unit, Centre for Migration and Health, ARNAS, Civico-Benfratelli Hospital, Palermo, Italy
-
j
Center for Disease Analysis Foundation, Lafayette, CO, United States
-
k
Department of Medicine i, University of Bonn, Bonn, Germany
-
l
Department of Global Health, University of Washington, Schools of Medicine and Public Health, Seattle, WA, United States
-
m
Department of Medicine, Clinical and Research Center, Humanitas Hospital, Rozzano, Italy
Abstract
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. The micro-elimination approach encourages stakeholders who are most knowledgeable about specific populations to engage with each other and also promotes the uptake of new models of care. Examples of micro-elimination target populations include medical patients, people who inject drugs, migrants, and prisoners, although candidate populations can be expected to vary greatly in different countries and subnational areas. © 2018 by Thieme Medical Publishers, Inc.
Author Keywords
Index Keywords
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049846307&doi=10.1055%2fs-0038-1666841&partnerID=40&md5=5361ddba89fde2dda69e42ed209038f8
DOI: 10.1055/s-0038-1666841
ISSN: 02728087
Cited by: 15
Original Language: English